Cell biology of antigen processing in vitro and in vivo

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 975-1028

  Trombetta, E Sergio ^a   Mellman, Ira ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presentation; Dendritic cells; Endocytosis; Proteolysis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CROSS PRESENTATION; CYTOLOGY; DENDRITIC CELL; ENDOCYTOSIS; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; ENDOCYTOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDES;

EID: 17644370329     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104538     Document Type: Review

References (375)

1. Zinkernagel RM, Hengartner H. 2001. Regulation of the immune response by antigen. Science 293:251-53
2. Malissen B, Price MP, Goverman JM, McMillan M, White J, et al. 1984. Gene transfer of H-2 class II genes: antigen presentation by mouse fibroblast and hamster B-cell lines. Cell 36:319-27
3. Rock KL, Goldberg AL. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739-79
4. Jackson MR, Peterson PA. 1993. Assembly and intracellular transport of MHC class I molecules. Annu. Rev. Cell Biol. 9:207-35
5. Pamer E, Cresswell P. 1998. Mechanism of MHC classI-restricted antigen processing. Annu. Rev. Immunol. 16:323-58
6. Heemels MT, Ploegh H. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463-91
7. York IA, Rock KL. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-96
8. Cresswell P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-93
9. Wolf P, Ploegh H. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11:267-306
10. Germain RN. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-99
11. Bryant P, Ploegh H. 2004. Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16:96-102
12. Robadey C, Wallny HJ, Demotz S. 1996. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116. Eur. J. Immunol. 26:1656-59
13. Schneider SC, Sercarz EE. 1997. Antigen processing differences among APC. Hum. Immunol. 54:148-58
14. Mellman I, Turley SJ, Steinman RM. 1998. Antigen processing for amateurs and professionals. Trends Cell Biol. 8:231-37
15. Lanzavecchia A. 1990. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T-lymphocytes. Annu. Rev. Immunol. 8:773-93
16. Watts C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15:821-50
17. Mellman I, Steinman RM. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255-58
18. Steinman RM, Mellman IS, Muller WA, Cohn ZA. 1983. Endocytosis and the recycling of plasma membrane. J. Cell Biol. 96:1-27
19. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immumol. 9:271-96
20. Inaba K, Metlay JP, Crowley MT, Steinman RM. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-40. Erratum. 1990. J. Exp. Med. 172(4): 1275
21. Inaba K, Metlay JP, Crowley MT, Steinman RM. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-40. Erratum. 1990. J. Exp. Med. 172(4): 1275
22. Crowley M, Inaba K, Steinman RM. 1990. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172:383-86
23. Steinman R, Inaba K. 1989. Immunogenicity: role of dendritic cells. BioEssays 10:145-52
24. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-52
25. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. 2004. Clearance of apoptotic cells; getting rid of the corpses. Mol. Cell 14:277-87
26. Aderem A, Underhill DM. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623
27. Itano AA, Jenkins MK. 2003. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4:733-39
28. von Andrian UH, Mempel TR. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-78
29. Catron DM, Itano AA, Pape KA, Mueller DL, Jenkins MK. 2004. Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity 21:341-47
30. Mempel TR, Henrickson SE, Von Andrian UH. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154-59
31. Randolph GJ. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13:267-74
32. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, et al. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47-57
33. Macpherson AJ, Uhr T. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303:1662-65
34. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, et al. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-44
35. Steinman RM, Hawiger D, Nussenzweig MC. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711
36. Unanue ER, Askonas BA. 1968. The immune response of mice to antigen in macrophages. Immunology 15:287-96
37. Chang MD, Stanley ER, Khalili H, Chisholm O, Pollard JW. 1995. Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response. Cell. Immunol. 162:146-52
38. Wiktor-Jedrzejczak W, Ansari AA, Szperl M, Urbanowska E. 1992. Distinct in vivo functions of two macrophage subpopulations as evidenced by studies using macrophage-deficient op/op mouse. Eur. J. Immunol. 22:1951-54
39. Delemarre FG, Kors N, van Rooijen N. 1990. The in situ immune response in popliteal lymph nodes of mice after macrophage depletion. Differential effects of macrophages on thymus-dependent and thymus-independent immune responses, Immunobiology 180:395-404
40. + T cells by exogenous cell-associated antigens. Immunity 17:211-20
41. + T cell immunity. J. Immunol. 171:5077-84
42. + dendritic cells is sufficient for control of Leishmania major. J. Exp. Med. 199:725-30
43. Lanzavecchia A, Sallusto F. 2001. Regulation of T cell immunity by dendritic cells. Cell 106:263-66
44. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235-47
45. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467-77
46. Delamarre L, Holcombe H, Mellman I. 2003. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198:111-22
47. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, et al. 1998. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-68
48. Inaba K, Steinman RM. 1986. Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering. J. Exp. Med. 163:247-61
49. Inaba K, Romani N, Steinman RM. 1989. An antigen-independent contact mechanism as an early step in T cell-proliferative responses to dendritic cells. J. Exp. Med. 170:527-42
50. Steinman RM, Inaba K. 1988. The binding of antigen presenting cells to T lymphocytes. Adv. Exp. Med. Biol. 237:31-41
51. Kropshofer H, Spindeldreher S, Rohn TA, Platania N, Grygar C, et al. 2002. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3:61-68
52. Rohn TA, Boes M, Wolters D, Spindeldreher S, Muller B, et al. 2004. Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization. Nat. Immunol. 5:909-18
53. Turley SJ, Inaba K, Steinman RM, Mellan I. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522-27
54. Bertho N, Cerny J, Kim YM, Fiebiger E, Ploegh H, Boes M. 2003. Requirements for T cell-polarized tubulation of class II+ compartments in dendritic cells. J. Immunol, 171:5689-96
55. Larsen CP, Steinman RM, Witmer PM, Hankins DF, Morris PJ, Austyn JM. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172:1483-93
56. Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, et al. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927-36
57. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299:1400-3
58. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, et al. 2004. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305:1153-57
59. Steinman RM, Swanson J. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182:283-88
60. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-18
61. West MA, Prescott AR, Eskelinen EL, Ridley AJ, Watts C. 2000. Rac is required for constitutive macropinocytosis by dendritic cells but does not control its down-regulation, Curr. Biol. 10:839-48
62. Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, et al. 2000. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102:325-34
63. Chow A, Mellman I. 2005. Old lysosomes, new tricks: dynamics of MHC class II transport in dendritic cells. Trends Immunol. In press
64. Chow A, Toomre D, Garrett W, Mellman I. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418:988-94
65. Inaba K, Pack M, Inaba M, Sakuta H, Isdell F, Steinman RM. 1997. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186:665-72
66. Steinman RM, Pack M, Inaba K. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25-37
67. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:1091-97
68. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-18
69. Wilson NS, El-Sukkari D, Belz GT, Smith CM, Steptoe RJ, et al. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187-94
70. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-61
71. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811
72. Liu Y. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-62
73. Carbone F, Heath W. 2003. The role of dendritic cell subsets in immunity to viruses. Curr. Opin. Immunol. 15:416-20
74. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-302
75. Banchereau J, Pascual V, Palucka AK. 2004. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 20:539-50
76. Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. 2004. T lymphocyte- endothelial cell interactions. Annu. Rev. Immunol. 22:683-709
77. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-19
78. Ostrand-Rosenberg S. 1994. Tumor immunotherapy: the tumor cell as an antigen-presenting cell. Curr. Opin. Immunol 6:722-27
79. Muntasell A, Carrascal M, Serradell L, van Veelen P, Verreck F, et al. 2002. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J. Immunol. 169:5052-60
80. Muntasell A, Carrascal M, Alvarez I, Serradell L, van Veelen P, et al. 2004. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands. J. Immunol 173:1085-93
81. Boon T, Van Pel A. 1989. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 29:75-79
82. Mayrand SM, Green WR. 1998. Nontraditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today 19:551-56
83. Shastri N, Schwab S, Serwold T. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463-93
84. Bullock TN, Eisenlohr LC. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1319-29
85. Saeterdal I, Bjorheim J, Lislerud K, Gjertsen MK, Bukholm IK, et al. 2001. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc. Natl. Acad. Sci. USA 98:13255-60
86. Probst-Kepper M, Stroobant V, Kridel R, Gaugier B, Landry C, et al. 2001. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CDS T lymphocytes. J. Exp. Med. 193:1189-98
87. Wang RF, Parkhurst MR, Kawakami Y, Robbins PF, Rosenberg SA. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183:1131-40
88. Rimoldi D, Rubio-Godoy V, Dutoit V, Lienard D, Salvi S, et al. 2000. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. J. Immunol. 165:7253-61
89. Saulquin X, Scotet E, Trautmann L, Peyrat MA, Halary F, et al. 2002. +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. J. Exp. Med. 195:353-58
90. Cardinaud S, Moris A, Fevrier M, Rohrlich PS, Weiss L, et al. 2004. Identification of cryptic MHC I-restricted epitopes encoded by HIV-I alternative reading frames. J. Exp. Med. 199:1053-63
91. Yewdell JW, Schubert U, Bennink JR. 2001. At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell Sci. 114:845-51
92. Lelouard H, Gatti E, Cappello F, Gresser O, Camosseto V, Pierre P. 2002. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 417:177-82
93. Lelouard H, Ferrand V, Marguet D, Bania J, Camosseto V, et al. 2004. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J. Cell Biol. 164:667-75
94. Mosse CA, Meadows L, Luckey CJ, Kittlesen DJ, Huczko EL, et al. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37-48
95. Zarling AL, Ficarro SB, White FM, Shabanowitz I, Hunt DF, Engelhard VH. 2000. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J. Exp. Med. 192:1755-62
96. Chen W, Yewdell JW, Levine RL, Bennink JR. 1999. Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J. Exp. Med. 189:1757-64
97. Shen L, Rock KL. 2004. Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. USA 101:3035-40
98. + T cell cross-priming via transfer of proteasome substrates. Science 304:1318-21
99. Wolkers MC, Brouwenstijn N, Bakker AH, Toebes M, Schumacher TN. 2004. Antigen bias in T cell cross-priming. Science 304:1314-17
100. Bacik I, Snyder HL, Anton LC, RUSS G, Chen W, et al. 1997. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J. Exp. Med. 186:479-87
101. Bonifacino JS, Weissman AM. 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Dev. Biol. 14:19-57
102. Ellgaard L, Molinari M, Helenius A. 1999. Setting the standards: quality control in the secretory pathway. Science 286:1882-88
103. Trombetta ES, Parodi AJ. 2003. Quality control and glycoprotein folding in the secretory pathway. Annu. Rev. Cell Dev. Biol. 19:649-76
104. Tsai B, Ye Y, Rapoport TA. 2002. Retrotranslocation of proteins from the endoplasmic reticulum into the cytosol. Nat. Rev. Mol. Cell Biol. 3:246-55
105. Lilley BN, Ploegh HL. 2004. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429:834-40
106. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA. 2004. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429:841-47
107. Furman MH, Ploegh H. 2002. Lessons from viral manipulation of protein disposal pathways. J. Clin. Invest. 110:875-79
108. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18:861-926
109. Yewdell JW, Hill AB. 2002. Viral interference with antigen presentation. Nat. Immunol. 3:1019-25
110. Wei ML, Cresswell P. 1992, HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443-46
111. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, et al. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264-66
112. Hombach J, Pircher H, Tonegawa S, Zinkernagel RM. 1995. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J. Exp. Med. 182:1615-19
113. Braciale TJ, Braciale VL, Winkler M, Stroynowski I, Hood L, et al. 1987. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J. Exp. Med. 166:678-92
114. Hanada K, Yewdell JW, Yang JC. 2004. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427:252-56
115. Vigneron N, Stroobant V, Chapiro J, Ooms A, Degiovanni G, et al. 2004. An antigenic peptide produced by peptide splicing in the proteasome. Science 304:587-90
116. Sigal LJ, Crotty S, Andino R, Rock KL. 1999. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398:77-80
117. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-62
118. Bachmann MF, Oxenius A, Pircher H, Hengartner H, Ashton-Richardt PA, et al. 1995. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25:1739-43
119. Kleijmeer MJ, Escola JN, UytdeHaag FG, Jakobson E, Griffith JM, et al. 2001. Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2:124-37
120. Berwin B, Rosser MF, Brinker KG, Nicchitta CV. 2002. Transfer of GRP94(Gp96)-associated peptides onto endosomal MHC class I molecules. Traffic 3:358-66
121. Ackerman AL, Cresswell P. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5:678-84
122. Harding CV, Song R. 1994. Phagocytic processing of exogenous paniculate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925-33
123. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783-91
124. Kovacsovics-Bankowski M, Rock KL. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243-46
125. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. 1999. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:362-68
126. - dendritic cells in vivo. J. Exp. Med. 196:817-27
127. Reis e Sousa C, Germain RN. 1995. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:841-51
128. Gil-Torregrosa BC, Lennon-Dumenil AM, Kessler B, Guermonprez P, Ploegh HL, et al. 2004. Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34:398-407
129. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, et al. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815-24
130. Rock KL. 1996. A new foreign policy: MHC class 1 molecules monitor the outside world. Immunol. Today 17:131-37
131. Steinman RM, Inaba K, Turley S, Pierre P, Mellman I. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60:562-67
132. Sandvig K, Van Deurs B. 2002. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18:1-24
133. Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, et al. 2001. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 12:2453-68
134. Smith DC, Lord JM, Roberts LM, Tartour E, Johannes L. 2002. 1st class ticket to class I: protein toxins as pathfinders for antigen presentation. Traffic 3:697-704
135. Anderson HA, Chen Y, Norkin LC. 1996. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7:1825-34
136. Pelkmans L, Kartenbeck J, Helenius A. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:473-83
137. Norkin LC, Anderson HA, Wolfrom SA, Oppenheim A. 2002. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 76:5156-66
138. Miesenbock G, Rothman JE. 1995. The capacity to retrieve escaped ER proteins extends to the trans-most cisterna of the Golgi stack. J. Cell Biol. 129:309-19
139. Gu F, Aniento F, Parton RG, Gruenberg J. 1997. Functional dissection of COP-I subunits in the biogenesis of multivesicular endosomes. J. Cell Biol. 139:1183-95
140. Whitney JA, Gomez M, Sheff D, Kreis TE, Mellman I. 1995. Cytoplasmic coat proteins involved in endosome function. Cell 83:703-13
141. Daro E, Sheff D, Gomez M, Kreis T, Mellman I. 1997. Inhibition of endosome function in CHO cells bearing a temperature-sensitive defect in the coatomer (COPI) component ε-COP. J. Cell Biol. 139:1747-59
142. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, et al. 2002. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110:119-31
143. Desjardins M. 2003. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol. 3:280-91
144. Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, et al. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402-6
145. Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert P, Amigorena S. 2003. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425:397-402
146. Ackerman AL, Kyritsis C, Tampe R, Cresswell P. 2003. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. USA 100:12889-94
147. Bajno L, Peng XR, Schreiber AD, Moore HP, Trimble WS, Grinstein S. 2000. Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation. J. Cell Biol. 149:697-706
148. Henry RM, Hoppe AD, Joshi N, Swanson JA. 2004. The uniformity of phagosome maturation in macrophages. J. Cell Biol. 164:185-94
149. Roy CR. 2002. Exploitation of the endoplasmic reticulum by bacterial pathogens. Trends Microbiol. 10:418-24
150. Fajardo M, Schleicher M, Noegel A, Bozzaro S, Killinger S, et al. 2004. Calnexin, calreticulin and cytoskeleton-associated proteins modulate uptake and growth of Legionella pneumophila in Dictyostelium discoideum. Microbiology 150:2825-35
151. Lizee G, Basha G, Tiong J, Julien JP, Tian M, et al. 2003. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4:1065-73
152. Michalek MT, Benacerraf B, Rock KL. 1992. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock. J. Immunol. 148:1016-24
153. Jacobson S, Sekaly RP, Jacobson CL, McFarland HF, Long EO. 1989. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1756-62
154. Nuchtern JG, Biddison WE, Klausner RD. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343:74-76
155. + cytotoxic T cell clones. J. Immunol. 142:2847-54
156. Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, et al. 1992. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 357:702-4
157. Brooks AG, McCluskey J. 1993. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. J. Immunol. 150:3690-97
158. Jaraquemada D, Marti M, Long EO. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp. Med. 172:947-54
159. Mukherjee P, Dani A, Bhatia S, Singh N, Rudensky AY, et al. 2001. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis. J. Immunol. 167:2632-41
160. Oxenius A, Bachmann MF, Ashton-Rickardt PG, Tonegawa S, Zinkernagel RM, Hengartner H. 1995. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25:3402-11
161. Oxenius A, Bachmann MF, Mathis D, Benoist C, Zinkernagel RM, Hengartner H. 1997. Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection. J. Immunol. 158:5717-26
162. Oukka M, Colucci-Guyon E, Tran PL, Cohen-Tannoudji M, Babinet C, et al. 1996. CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity 4:545-53
163. Sant AJ. 1994. Endogenous antigen presentation by MHC class II molecules. Immunol. Res. 13:253-67
164. Hunt DF, Michel H, Dickinson TA, Shabanowitz J, Cox AL, et al. 1992. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256:1817-20
165. Nelson CA, Roof RW, McCourt DW, Unanue ER. 1992. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc. Natl. Acad. Sci. USA 89:7380-83
166. Engelhard VH. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181-207
167. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622-27
168. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, et al. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764-68
169. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27-47
170. Newcomb JR, Cresswell P. 1993. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chai n-associated α β dimers. J. Immunol. 150:499-507
171. Dongre AR, Kovats S, deRoos P, McCormack AL, Nakagawa T, et al. 2001. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31:1485-94
172. Lechler R, Aichinger G, Lightstone L. 1996. The endogenous pathway of MHC class II antigen presentation. Immunol. Rev. 151:51-79
173. Nimmerjahn F, Milosevic S, Behrends U, Jaffee EM, Pardoll DM, et al. 2003. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 33:1250-59
174. Munz C. 2004. Epstein-Barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target. J. Exp. Med. 199:1301-4
175. Lich JD, Elliott JF, Blum JS. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J. Exp. Med. 191:1513-24
176. Harding CV, Ramachandra L, Wick MJ. 2003. Interaction of bacteria with antigen presenting cells: influences on antigen presentation and antibacterial immunity. Curr. Opin. Immunol. 15:112-19
177. Sacks D, Sher A. 2002. Evasion of innate immunity by parasitic protozoa. Nat. Immunol. 3:1041-47
178. Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ. 1999. Extracellular antigen processing and presentation by immature dendritic cells. Proc. Natl. Acad. Sci. USA 96:15056-61
179. Santambrogio L, Sato AK, Fischer FR, Dorf ME, Stern LJ. 1999. Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc. Natl. Acad. Sci. USA 96:15050-55
180. Andersson T, Patwardhan A, Emilson A, Carlsson K, Scheynius A. 1998. HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cells. Arch. Dermatol. Res. 290:674-80
181. Arndt SO, Vogt AB, Markovic-Plese S, Martin R, Moldenhauer G, et al. 2000. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 19:1241-51
182. Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474-77
183. Denzin LK, Cresswell P. 1995. HLA-DM induces CLIP dissociation from MHC class II α β dimers and facilitates peptide loading. Cell 82:155-65
184. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, et al. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-6
185. Pu Z, Carrero JA, Unanue ER. 2002. Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 99:8844-49
186. Pu Z,Lovitch SB, Bikoff EK, Unanue ER. 2004. T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 20:467-76
187. Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, et al. 2004. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 199:271-81
188. Underhill DM, Ozinsky A. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20:825-52
189. Blander JM, Medzhitov R. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014-18
190. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, et al. 2004. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199:81-90
191. Mellman I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:575-625
192. Conner SD, Schmid SL. 2003. Regulated portals of entry into the cell. Nature 422:37-44
193. Sinai AP, Joiner KA. 1997. Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu. Rev. Microbiol. 51:415-62
194. Montesano R, Roth J, Robert A, Orci L. 1982. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 296:651-53
195. Pelkmans L, Helenius A. 2003. Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 15:414-22
196. Sallusto F, Cella M, Danieli C, Lanzavecchia A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400
197. Silverstein SC, Steinman RM, Cohn ZA. 1977. Endocytosis. Annu. Rev. Biochem. 46:669-722
198. Delamarre L, Pack M, Chang H, Mellman I, Trombetta S. 2005. Differential lysosomal proteolysis in antigen presenting cells determines antigen fate in vivo. Science. In press
199. Zhong G, Reis e Sousa C, Germain RN. 1997. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186:673-82
200. Lazzarino DA, Blier P, Mellman I. 1998. The monomeric guanosine triphosphatase rab4 controls an essential step on the pathway of receptor-mediated antigen processing in B cells. J. Exp. Med. 188:1769-74
201. Lanzavecchia A. 1985. Antigen-specific interaction between T and B cells. Nature 314:537-39
202. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, et al. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151-55
203. Inaba K, Swiggard WJ, Inaba M, Meltzer J, Mirza A, et al. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163:148-56
204. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, et al. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:673-84
205. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-79
206. + T cell tolerance. J. Exp. Med. 196:1627-38
207. Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, et al. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808-12
208. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, et al. 1999. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-80
209. Heyman B. 2000. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18:709-37
210. Tew JG, Wu J, Fakher M, Szakal AK, Qin D. 2001. Follicular dendritic cells: beyond the necessity of T-cell help. Trends Immunol. 22:361-67
211. Yoshida M, Claypool SM, Wagner JS, Mizoguchi E, Mizoguchi A, et al. 2004. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20:769-83
212. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. 1995. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 181:1957-63
213. Jaume JC, Parry SL, Madec AM, Sonderstrup G, Baekkeskov S. 2002. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J. Immunol. 169:665-72
214. Lankar D, Vincent-Schneider H, Eriken V, Yokozeki T, Raposo G, Bonnerot C. 2002. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation. J. Exp. Med. 195:461-72
215. Berwin B, Hart JP, Rice S, Gass C, Pizzo SV, et al. 2003. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 22:6127-36
216. Becker T, Hartl FU, Wieland F. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol 158:1277-85
217. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-103
218. Geijtenbeek TBH, van Vliet SJ, Engering A, 't Hart BA, van Kooyk Y. 2004. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 22:33-54
219. Cossart P, Sansonetti PJ. 2004. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304:242-48
220. Wai SN, Lindmark B, Soderblom T, Takade A, Westermark M, et al. 2003. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115:25-35
221. Dal Monte P, Szoka FC Jr. 1989. Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors. J. Immunol. 142:1437-43
222. Stockinger B. 1992. Capacity of antigen uptake by B cells, fibroblasts or macrophages determines efficiency of presentation of a soluble self antigen (C5) to T lymphocytes. Eur. J. Immunol. 22:1271-78
223. Galelli A, Chariot B, Deriaud E, Leclerc C. 1993. B cells do not present antigen covalently linked to microspheres. Immunology 79:69-76
224. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, Rock KL. 1996. Analysis of MHC class II presentation of paniculate antigens of B lymphocytes. J. Immunol. 156:2809-18
225. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188:2163-73
226. Fleeton MN, Contractor N, Leon F, Wetzel JD, Dermody TS, Kelsall BL. 2004. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200:235-45
227. Ravichandran KS. 2003. "Recruitment signals" from apoptotic cells: invitation to a quiet meal. Cell 113:817-20
228. Larsson M, Fonteneau JF, Bhardwaj N. 2001. Dendritic cells resurrect antigens from dead cells. Trends Immunol. 22:141-48
229. Fonteneau JF, Larsson M, Bhardwaj N. 2002. Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. Curr. Opin. Immunol. 14:471-77
230. Steinman RM, Turley S, Mellman I, Inaba K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411-16
231. Savill J, Dransfield I, Gregory C, Haslett C. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965-75
232. Ferry H, Jones M, Vaux DJ, Roberts IS, Cornall RJ. 2003. The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J. Exp. Med. 198:1415-25
233. Golovina TN, Wherry EJ, Bullock TN, Eisenlohr LC. 2002. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. J. Immunol. 168:2667-75
234. Mougneau E, Hugues S, Glaichenhaus N. 2002. Antigen presentation by dendritic cells in vivo. J. Exp. Med. 196:1013-16
235. Reddien PW, Horvitz HR. 2004. The engulfment process of programmed cell death in Caenorhabditis elegans. Annu. Rev. Cell Dev. Biol. 20:193-221
236. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM. 2001. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166:3717-23
237. Joly E, Hudrisier D. 2003. What is trogocytosis and what is its purpose? Nat. Immunol. 4:815
238. Huang JF, Yang Y, Sepulveda H, Shi W, Hwang I, et al. 1999. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286:952-54
239. Batista FD, Iber D, Neuberger MS. 2001, B cells acquire antigen from target cells after synapse formation. Nature 411:489-94
240. + dendritic cells in vivo. J. Exp. Med. 195:683-94
241. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. 2004. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199:283-93
242. Sornasse T, Flamand V, De Becker G, Bazin H, Tielemans F, et al. 1992. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J. Exp. Med. 175:15-21
243. Wykes M, Pombo A, Jenkins C, MacPherson GG. 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161:1313-19
244. MacPherson G, Kushnir N, Wykes M. 1999. Dendritic cells, B cells and the regulation of antibody synthesis. Immunol. Rev. 172:325-34
245. Colino J, Shen Y, Snapper CM. 2002. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein-and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J. Exp. Med. 195:1-13
246. Seiberg M. 2001. Keratinocyte-melanocyte interactions during melanosome transfer. Pigment Cell Res. 14:236-42
247. Cagan RL, Kramer H, Hart AC, Zipursky SL. 1992. The bride of sevenless and sevenless interaction: internalization of a transmembrane ligand. Cell 69:393-99
248. Henderson ST, Gao D, Lambie EJ, Kimble J. 1994. lag-2 may encode a signaling ligand for the GLP-I and LIN-12 receptors of C. elegans. Development 120:2913-24
249. York IA, Goldberg AL, Mo XY, Rock KL. 1999. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172:49-66
250. Niedermann G, Geier E, Lucchiari-Hartz M, Hitziger N, Ramsperger A, Eichmann K. 1999. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens. Immunol. Rev. 172:29-48
251. Voges D, Zwickl P, Baumeister W. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1015-68
252. Hill CP, Masters EI, Whitby FG. 2002. The 11S regulators of 20S proteasome activity. Curr. Top. Microbiol. Immunol. 268:73-89
253. Whitby FG, Masters EI, Kramer L, Knowlton JR, Yao Y, et al. 2000. Structural basis for the activation of 20S proteasomes by US regulators. Nature 408:115-20
254. Goldberg AL, Cascio P, Saric T, Rock KL. 2002. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol. Immunol. 39:147-64
255. Cascio P, Call M, Petre BM, Walz T, Goldberg AL. 2002. Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J. 21:2636-45
256. Kessler B, Hong X, Petrovic J, Borodovsky A, Dantuma NP, et al. 2003. Pathways accessory to proteasomal proteolysis are less efficient in major histocompatibility complex class I antigen production. J Biol. Chem. 278:10013-21
257. Kessler BM, Glas R, Ploegh HL. 2002. MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation. Mol. Immunol. 39:171-79
258. Rock KL, York IA, Goldberg AL. 2004. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5:670-77
259. Kunisawa J, Shastri N. 2003. The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol. Cell 12:565-76
260. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 71:963-72
261. Snyder HL, Yewdell JW, Bennink JR. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389-94
262. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419:480-83
263. York IA, Chang SC, Saric T, Keys JA, Favreau JM, et al. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3:1177-84
264. Falk K, Rotzschke O, Rammensee HG. 1990. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248-51
265. Brouwenstijn N, Serwold T, Shastri N. 2001. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. Immunity 15:95-104
266. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199:905-15
267. Shen L, Sigal LJ, Boes M, Rock KL. 2004. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21:155-65
268. De Duve C, Wattiaux R. 1966. Functions of lysosomes. Anniv. Rev. Physiol. 28:435-92
269. Kornfeld S, Mellman I. 1989. The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5:483-525
270. Pierre P, Denzin LK, Hammond C, Drake JR, Amigorena S, et al. 1996. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 4:229-39
271. Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ. 1997. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell Biol. 139:639-49
272. Werdelin O. 1986. Determinant protection. A hypothesis for the activity of immune response genes in the processing and presentation of antigens by macrophages. Scand. J. Immunol. 24:625-36
273. Deng H, Apple R, Clare-Salzler M, Trembleau S, Mathis D, et al. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1675-80
274. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-66
275. Sercarz EE, Maverakis E. 2003. MHC-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3:621-29
276. Lee P, Matsueda GR, Allen PM. 1988. T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing. J. Immunol. 140:1063-68
277. Donermeyer DL, Allen PM. 1989. Binding to Ia protects an immunogenic peptide from proteolytic degradation. J. Immunol. 142:1063-68
278. Sette A, Adorini L, Colon SM, Buus S, Grey HM. 1989. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143:1265-67
279. Castellino F, Zappacosta F, Coligan JE, Germain RN. 1998. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J. Immunol. 161:4048-57
280. Jensen PE. 1993. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150:3347-56
281. Lindner R, Unanue ER. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15:6910-20
282. Streicher HZ, Berkower IJ, Busch M, Gurd FR, Berzofsky JA. 1984. Antigen conformation determines processing requirements for T-cell activation. Proc. Natl. Acad. Sci. USA 81:6831-35
283. Mouritsen S, Meldal M, Werdelin O, Hansen AS, Buus S. 1992. MHC molecules protect T cell epitopes against proteolytic destruction. J. Immunol. 149:1987-93
284. Villadangos JA, Driesen C, Shi G, Chapman HA, Ploegh H. 2000. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2M. EMBO J. 19:882-91
285. Davidson HW, Reid PA, Lanzavecchia A, Watts C. 1991. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67:105-16
286. Grewal IS, Moudgil KD, Sercarz EE. 1995. Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen. Proc. Natl. Acad. Sci. USA 92:1779-83
287. Barrett A, Rawlings N, Woessner J, eds. 2003. Handbook of Proteolytic Enzymes. New York: Academic Press. 2nd ed.
288. Shi GP, Webb AC, Foster KE, Knoll JH, Lemere CA, et al. 1994. Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269:11530-36
289. Villadangos JA, Ploegh HL. 2000. Proteolysis in MHC class II antigen presentation: Who's in charge? Immunity 12:233-39
290. Lennon-Dumenil AM, Bakker AH, Wolf-Bryant P, Ploegh HL, Lagaudriere-Gesbert C. 2002. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr. Opin. Immunol. 14:15-21
291. Honey K, Rudensky AY. 2003. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3:472-82
292. Driessen C, Lennon-Dumenil AM, Ploegh HL. 2001. Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcγ receptors. Eur. J. Immunol. 31:1592-601
293. + T cell selection independently of its effect on invariant chain: A role in the generation of positively selecting peptide ligands. J. Exp. Med. 195:1349-58
294. Manoury B, Mazzeo D, Li DN, Billson J, Loak K, et al. 2003. Asparagine endopep-tidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity 18:489-98
295. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, et al. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280:450-53
296. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10:207-17
297. Driessen C, Bryant RA, Lennon-Dumenil AM, Villadangos JA, Bryant PW, et al. 1999. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol. 147:775-90
298. Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, et al. 2000. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:1177-86
299. Sant AJ, Miller J. 1994. MHC class II antigen processing: biology of invariant chain. Curr. Opin. Immunol. 6:57-63
300. Romagnoli P, Layet C, Yewdell J, Bakke O, Germain RN. 1993. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J. Exp. Med. 177:583-96
301. b peptide-binding motif. J. Mol. Biol. 326:1157-74
302. Antoniou AN, Blackwood SL, Mazzeo D, Watts C. 2000. Control of antigen presentation by a single protease cleavage site. Immunity 12:391-98
303. Manoury B, Hewitt E, Morrice N, Dando P, Barren A, Watts C. 1998. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396:695-99
304. Schneider SC, Ohmen J, Fosdick L, Gladstone B, Guo J, et al. 2000. Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. J. Immunol. 165:20-23
305. Hording CV, Collins DS, Slot JW, Geuze HJ, Unanue ER. 1991. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64:393-401
306. Pure E, Inaba K, Crowley MT, Tardelli L, Witmer PM, et al. 1990. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J. Exp. Med. 172:1459-69
307. Romani N, Koide S, Crowley M, Witmer PM, Livingstone AM, et al. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1169-78
308. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, et al. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-92
309. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782-87
310. + T cells. Science 257:383-87
311. Kampgen E, Koch N, Koch F, Stoger P, Heufler C, et al. 1991. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 88:3014-18
312. Pierre P, Mellman I. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93:1135-45
313. Ni J, Fernandez MA, Danielsson L, Chillakuru RA, Zhang J, et al. 1998. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J. Biol. Chem. 273:24797-804
314. Halfon S, Ford J, Foster J, Dowling L, Lucian L, et al. 1998. Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J. Biol. Chem. 273:16400-8
315. Manickasingham S, Reis e Sousa C. 2000. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J. Immunol. 165:5027-34
316. Veeraswamy RK, Cella M, Colonna M, Unanue ER. 2003. Dendritic cells process and present antigens across a range of maturation states. J. Immunol. 170:5367-72
317. Li DN, Matthews SP, Antoniou AN, Mazzeo D, Watts C. 2003. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278:38980-90
318. Lautwein A, Burster T, Lennon-Dumenil AM, Overkleeft HS, Weber E, et al. 2002. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 32:3348-57
319. Desjardins M, Huber LA, Parton RG, Griffiths G. 1994. Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus. J. Cell Biol. 124:677-88
320. Lennon-Dumenil AM, Bakker AH, Maehr R, Fiebiger E, Overkleeft HS, et al. 2002. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 196:529-40
321. Barois N, de Saint-Vis B, Lebecque S, Geuze HJ, Kleijmeer MJ. 2002. MHC class II compartments in human dendritic cells undergo profound structural changes upon activation. Traffic 3:894-905
322. Jensen PE. 1990. Regulation of antigen presentation by acidic pH. J. Exp. Med. 171:1779-84
323. Jensen PE. 1991. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174:1111-20
324. Avva RR, Cresswell P. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763-74
325. Weber DA, Evavold BD, Jensen PE. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618-20
326. Phan UT, Arunachalam B, Cresswell P. 2000. Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J. Biol. Chem. 275:25907-14
327. Molinari M, Salio M, Galli C, Norais N, Rappuoli R, et al. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187:135-40
328. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, et al. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-81
329. Hackam DJ, Rotstein OD, Zhang W, Gruenheid S, Gros P, Grinstein S. 1998. Host resistance to intracellular infection: Mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med. 188:351-64
330. +-ATPase activity in murine peritoneal macrophages. J. Biol. Chem. 271:2005-11
331. Fiebiger E, Meraner P, Weber E, Fang IF, Stingl G, et al. 2001. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 193:881-92
332. Drakesmith H, O'Neil D, Schneider SC, Sinks M, Medd P, et al. 1998. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen. Proc. Natl. Acad. Sci. USA 95:14903-8
333. Mellman I, Fuchs R, Helenius A. 1986. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55:663-700
334. +)-ATPase. Annu. Rev. Cell Dev. Biol. 13:779-808
335. +)-ATPases-nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 3:94-103
336. Kane PM. 2000. Regulation of V-ATPases by reversible disassembly. FEBS Lett. 469:137-41
337. Sumner JP, Dow JA, Earley FG, Klein U, Jager D, Wieczorek H. 1995. Regulation of plasma membrane V-ATPase activity by dissociation of peripheral subunits. J. Biol. Chem. 270:5649-53
338. Mallya SK, Partin JS, Valdizan MC, Lennarz WJ. 1992. Proteolysis of the major yolk glycoproteins is regulated by acidification of the yolk platelets in sea urchin embryos. J. Cell Biol. 117:1211-21
339. Fagotto F. 1995. Regulation of yolk degradation, or how to make sleepy lysosomes. J. Cell Sci. 108:3645-47
340. Fagotto F, Maxfield FR. 1994. Changes in yolk platelet pH during Xenopus laevis development correlate with yolk utilization. A quantitative confocal microscopy study. J. Cell Sci. 107:3325-37
341. Barasch J, Gershon MD, Nunez EA, Tamir H, al-Awqati Q. 1988. Thyrotropin induces the acidification of the secretory granules of parafollicular cells by increasing the chloride conductance of the granular membrane. J. Cell Biol. 107:2137-47
342. Haque MA, Li P, Jackson SK, Zarour HM, Hawes JW, et al. 2002. Absence of γ-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J. Exp. Med. 195:1267-77
343. Zamvil SS, Mitchell DJ, Moore AC, Kitamura K, Steinman L, Rothbard JB. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258-60
344. Mamula MJ, Gee RJ, Elliott JI, Sette A, Southwood S, et al. 1999. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J. Biol. Chem. 274:22321-27
345. Sollid LM. 2000. Molecular basis of celiac disease. Annu. Rev. Immunol. 18:53-81
346. Cirrito TP, Pu Z, Deck MB, Unanue ER. 2001. Deamidation of asparagine in a major histocompatibility complex-bound peptide affects T cell recognition but does not explain type B reactivity. J. Exp. Med. 194:1165-70
347. Cao L, Sun D, Whitaker JN. 1998. Citrullinated myelin basic protein induces experimental autoimmune encephalomyelitis in Lewis rats through a diverse T cell repertoire. J. Neuroimmunol. 88:21-29
348. van Stipdonk MJ, Willems AA, Amor S, Persoon-Deen C, Travers PJ, et al. 1998. T cells discriminate between differentially phosphorylated forms of αB-crystallin, a major central nervous system myelin antigen. Int. Immunol. 10:943-50
349. Dudler T, Altmann F, Carballido JM, Blaser K. 1995. Carbohydrate- dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients. Eur. J. Immunol. 25:538-42
350. Corthay A, Backlund J, Broddefalk J, Michaelsson E, Goldschmidt TJ, et al. 1998. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur. J. Immunol. 28:2580-90
351. Haurum JS, Arsequell G, Lellouch AC, Wong SY, Dwek RA, et al. 1994. Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J. Exp. Med. 180:739-44
352. Glithero A, Tormo J, Haurum JS, Arsequell G, Valencia G, et al. 1999. Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity 10:63-74
353. Speir JA, Abdel-Motal UM, Jondal M, Wilson IA. 1999. Crystal structure of an MH7 class 1 presented glycopeptide that generates carbohydrate-specific CTL. Immunity 10:51-61
354. ++ reactive human T cell clone. J. Exp. Med. 197:567-74
355. Engelhard VH, Brickner AG, Zarling AL. 2002. Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol. Immunol. 39:127-37
356. Vlad AM, Muller S, Cudic M, Paulsen H, Otvos L Jr, et al. 2002. Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells. J. Exp. Med. 196:1435-46
357. Alfonso C, Karlsson L. 2000. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18:113-42
358. Brocke P, Garbi N, Momburg F, Hammerling GJ. 2002. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr. Opin. Immunol. 14:22-29
359. Villadangos JA, Cardoso M, Steptoe RJ, van Berkel D, Pooley J, et al. 2001. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14:739-49
360. Steinman RM, Kaplan G, Witmer MD, Cohn ZA. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149:1-16
361. Stossel H, Koch F, Kampgen E, Stoger P, Lenz A, et al. 1990. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells. J. Exp. Med. 172:1471-82
362. Kleijmeer MJ, Oorschot VM, Geuze HJ. 1994. Human resident Langerhans cells display a lysosomal compartment enriched in MHC class II. J. Invest. Dermatol. 103:516-23
363. Kleijmeer M, Ramm G, Schuurhuis D, Griffith J, Rescigno M, et al. 2001. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 155:53-63
364. Katzmann DJ, Odorizzi G, Emr SD. 2002. Receptor downregulation and
365. Boes M, Cerny J, Massol R, Opden Brouw M, Kirchhausen T, et al. 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418:983-88
366. Thery C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2:569-79
367. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. 2000. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113(Part19):3365-74
368. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, et al. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166:7309-18
369. Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, et al. 1999. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 147:599-610
370. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, et al. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:594-600
371. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7:297-303
372. Stinchcombe J, Bossi G, Griffiths GM. 2004. Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55-59
373. Fehling H, Viville S, van Ewijk W, Benoist C, Mathis D. 1989. Fine-tuning of MHC class II gene expression in defined microenvironments. Trends Genet. 5:342-47
374. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, et al. 2002. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158:1119-31
375. Touret N, Paroutis P, Grinstein S. 2005. The nature of the phagosomal membrane: endoplasmic reticulum vs. plasmalemma. J. Leuk. Biol. In press